In a mouse study published in Cancer Discovery, researchers at Yale have offered a narrow but telling observation about pancreatic cancer: the kind of fat we eat may matter more than how much we eat. Oleic acid, the main fat in olive oil, appeared to speed the growth of tumours, while omega-3 fatty acids from fish and flaxseed slowed them. The story belongs to a long human effort to understand how what we eat shapes a disease that is quietly lethal, but these results remain in animals, and their meaning for people has yet to be written.
Mouse Study Links Fat Type to Pancreatic Tumour Growth, But Human Evidence Is Lacking
It is the type of fat, not just the total amount
Mark
So what exactly did the study find?
Mimi
In mice, oleic acid, the main fat in olive oil, was linked to faster pancreatic tumour growth, and omega-3s slowed it down.
Mark
That sounds like a warning about olive oil.
Mimi
Not quite. The report says you needn't eliminate it, just regulate the amount.
Luke
And that advice is the reporter's gloss. The study itself is in mice, and the piece says plainly there's no final proof in humans.
Mark
The headline mentions a 50 percent risk reduction. Where does that come from?
Luke
Nowhere in the study as described. That figure isn't supported, so I wouldn't repeat it.
Mimi
What Ruiz actually said is that the type of fat matters, not just the total.
Mark
Did they look at whole diets?
Mimi
No. They focused on fat type alone, not the wider factors that shape cancer risk.
Luke
So what's known is a mouse result. What's unknown is whether people respond the same way at normal dietary amounts.
Der Puls
- A Yale-led mouse study has linked oleic acid, the fat in olive oil, to faster growth of pancreatic tumours, unsettling a long-held sense that olive oil is simply benign.
- In the same models, omega-3 fatty acids from fatty fish and flaxseed slowed tumour development, offering a sharp contrast between two fats that are often grouped together.
- The headline's promise of a 50 percent risk reduction collides with the study's actual scope, which covers only mice and only the type of fat consumed.
- Researchers have not yet tested these findings in people, so the story stands at an open threshold where human trials will decide whether the results hold.
In a mouse study published in Cancer Discovery, researchers at Yale have offered a narrow but telling observation about pancreatic cancer: the kind of fat we eat may matter more than how much we eat. Oleic acid, the main fat in olive oil, appeared to speed the growth of tumours, while omega-3 fatty acids from fish and flaxseed slowed them. The story belongs to a long human effort to understand how what we eat shapes a disease that is quietly lethal, but these results remain in animals, and their meaning for people has yet to be written.
A study in mice, published in Cancer Discovery, is drawing attention for a narrow but striking claim about pancreatic cancer. The work, led by Christian Felipe Ruiz at Yale School of Medicine, suggests that the type of fat in the diet may matter more than the total amount consumed.
Pancreatic cancer is highly lethal and often caught late, and its mortality remains high even though it is less common than many other cancers. Nutritionists have long linked dietary fat to cancer risk, and this team set out to separate which fats push the disease forward and which hold it back.
The results were mixed in a revealing way. Oleic acid, the main fat in olive oil, was tied to faster growth of pancreatic ductal adenocarcinoma in the mouse models. Omega-3 fatty acids, found in fatty fish and flaxseed, significantly slowed tumour development. Ruiz noted that outcomes can diverge completely depending on the fat involved.
The caveats are essential. These findings come from animals, there is no final proof in humans, and the study did not account for wider diet and lifestyle factors. The headline's 50 percent risk reduction is not supported by what was reported.
The practical message is measured: there is no need to abandon olive oil, though moderation may be wise, and reliable omega-3 sources such as salmon, sardines, mackerel, nuts, seeds and chia remain worthwhile. Diet is a first step, not a cure. The next question is whether human studies will confirm what the mice have shown.
A study in mice, published in Cancer Discovery, the journal of the American Association for Cancer Research, is drawing attention for a narrow claim about pancreatic cancer: the kind of fat in the diet may matter more than the total amount. The work was led by Christian Felipe Ruiz, PhD, an associate research scientist in the Department of Genetics at Yale School of Medicine.
The backdrop is a cancer that the International Agency for Research on Cancer describes as highly lethal and often underdiagnosed. It occurs less often across populations than many other cancers, but its mortality rate is high. Nutritionists have long stressed the role of dietary fat in cancer risk, and this study tried to separate which fats do what.
Ruiz put the finding simply: it is the type of fat being consumed, not just total fat content. He added that depending on the fat, outcomes can go in completely different directions. Some fats promoted cancer, as the team expected, while others were very good at suppressing it.
The fat tied to faster tumour growth was oleic acid, the main fatty acid in olive oil. It is a monounsaturated fatty acid, also found in high-oleic safflower and sunflower oils, peanuts and lard. In the study models, it was linked to quicker growth of pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer and one of the deadliest cancers overall.
On the other side were omega-3 fatty acids, found in fatty fish and flaxseeds. In the mouse work, they slowed tumour development significantly. The NDTV report adds that omega-3s can support immune function, which may weaken as cancer cells multiply. It also notes that the body does not make omega-3s on its own, so they must come from food.
The limits matter here. The research was done in mice, and the report states there is no final proof in humans. The researchers also looked only at fat type, not the wider dietary and lifestyle factors that shape cancer risk. The headline on the NDTV piece promises a 50 percent risk reduction, but the study as described does not support a figure like that.
The practical advice in the report is cautious. It suggests you need not drop olive oil, but may want to moderate the amount, and it recommends reliable omega-3 sources: salmon, sardines and mackerel, nuts and seeds, and plant sources such as chia seeds, hemp seed and perilla oil. It points to research in The American Journal of Clinical Nutrition on the need for adequate healthy fats. It also lists other risk factors: highly processed fats, excess saturated fat, obesity, smoking and diabetes.
Diet, the report concludes, is a first step but not a cure or a guarantee, and environment and stress also play a part. What to watch for is whether the oleic acid and omega-3 findings are tested in human studies, which would show if the mouse results hold.
Bemerkenswerte Zitate
It's really the type of fat that you're consuming, not just total fat content.— Christian Felipe Ruiz, PhD, Yale School of Medicine
Möchten Sie die ganze Geschichte?
Das Original lesen bei NDTV.com ↗
Science & Space